Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Selected criteria sets and satisfaction at baseline among 708 DESIR patients

From: Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Criteria set origin

Patients ever satisfying criteria set (n) and percent of total (N = 708)

Diagnosis and disease severity criteria

France

n = 197 (27.8%)

BASDAI ≥4

New York criteria for AS OR involvement of SJ OR spine by X-ray, CT or MRI

Physician’s Global Assessment ≥4

Germany

n = 175 (24.7%)

BASDAI ≥4

ASAS criteria

Positive MRI or Elevated CRPb (i.e., minimum 1 of 2 criteria)

Canada

n = 169 (23.8%)

BASDAI ≥4

Sacroiilitis or spinal inflammation on X-ray, CT or MRI

Elevated CRP or ESR and/or Inflammatory lesions in the sacroiliac joints and/or spine on MRI and/or Expert opiniona (Minimum 2 of 3 criteria)

United Kingdom

n = 86 (12.1%)

BASDAI ≥4

Modified New York criteria for AS

Spinal pain in last week 4/10 VAS

Hong Kong

n = 61 (8.6%)

BASDAI ≥4

Modified New York criteria for AS

Morning stiffness ≥45 min

Inflammatory back pain ≥40/100 VAS

Patient Global Assessment ≥40/100 VAS

  1. CT computerized tomography, MRI magnetic resonance imaging, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, AS ankylosing spondylitis, CRP C-reactive protein, ESR erythrocyte sedimentation rate, SJ sacroiliac joint, VAS visual analogue scale
  2. aPositive expert opinion defined in the analysis as Physician’s Global Assessment ≥4
  3. bNA at baseline, values reported for month 6